Analysts Predict Market Returns for the Next Decade
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Source: Fool
- Market Return Expectations: Vanguard anticipates average annual returns of only 4% to 5% over the next decade, while Goldman Sachs' Peter Oppenheimer believes U.S. stocks will underperform compared to global markets, highlighting increasing market uncertainty.
- Tobacco Industry Comparison: While Altria Group boasts a forward dividend yield of 5.9%, Philip Morris International's 3.6% yield is backed by stronger performance, particularly with a 15% revenue growth in smoke-free products, indicating a long-term competitive edge.
- Pharmaceutical Industry Challenges: Merck's cancer drug Keytruda will lose patent protections starting in 2028; however, the company expects to generate over $70 billion in annual revenue in the next decade, showcasing the potential of its new product pipeline.
- Uniqueness of Tech Stocks: IBM, a technology company, has raised its dividend for 31 consecutive years with a forward yield of 3%, and its software and consulting services account for 78% of total revenue, providing stable cash flow and dividend support amid economic fluctuations.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PM?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PM
Wall Street analysts forecast PM stock price to rise
11 Analyst Rating
8 Buy
3 Hold
0 Sell
Moderate Buy
Current: 166.380
Low
175.00
Averages
191.95
High
210.00
Current: 166.380
Low
175.00
Averages
191.95
High
210.00
About PM
Philip Morris International Inc. is an international tobacco company. The Company’s product portfolio primarily consists of cigarettes and smoke-free products. Its smoke-free business (SFB) also includes wellness and healthcare products, as well as consumer accessories, such as lighters and matches. The Company’s segments include Europe Region; South and Southeast Asia, Commonwealth of Independent States, Middle East and Africa Region (SSEA, CIS & MEA); East Asia, Australia & PMI Global Travel Retail (EA, AU & PMI GTR), and Americas Region. The Company's brands include Marlboro, HEETS, IQOS, IQOS ILUMA, TEREA, VEEV and ZYN. Its IQOS smoke-free product brand portfolio includes heated tobacco and nicotine-containing vapor products. Its international cigarette brands are Chesterfield, L&M, and Philip Morris. It also owns a number of local cigarette brands, such as Dji Sam Soe and Sampoerna A in Indonesia, and Fortune and Jackpot in the Philippines.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
PMI Recognized for Fourth Year in Forbes Net Zero Leaders List
- Net Zero Progress: PMI has been recognized for the fourth consecutive year in Forbes' Net Zero Leaders list, showcasing its significant achievements in advancing climate action across global operations, marking its commitment to achieving net zero emissions by 2040, ahead of most companies targeting 2050.
- Industry Leadership: PMI ranked first in the fast-moving consumer goods category and fourth overall, reflecting its excellent risk management, operational strength, and governance capabilities, further solidifying its leadership position in climate action.
- Climate Strategy Enhancement: PMI published an updated Climate Transition Plan outlining actions, governance, timelines, and targets to achieve net zero GHG emissions by 2040, demonstrating the company's firm commitment to long-term value creation.
- Investment and Innovation: Since 2008, PMI has invested over $16 billion in developing smoke-free products, with an estimated 43% of net revenues coming from these products by 2025, indicating the strategic importance of driving sustainable development and market transformation.
See More
Analysts Predict Market Returns for the Next Decade
- Market Return Expectations: Vanguard anticipates average annual returns of only 4% to 5% over the next decade, while Goldman Sachs' Peter Oppenheimer believes U.S. stocks will underperform compared to global markets, highlighting increasing market uncertainty.
- Tobacco Industry Comparison: While Altria Group boasts a forward dividend yield of 5.9%, Philip Morris International's 3.6% yield is backed by stronger performance, particularly with a 15% revenue growth in smoke-free products, indicating a long-term competitive edge.
- Pharmaceutical Industry Challenges: Merck's cancer drug Keytruda will lose patent protections starting in 2028; however, the company expects to generate over $70 billion in annual revenue in the next decade, showcasing the potential of its new product pipeline.
- Uniqueness of Tech Stocks: IBM, a technology company, has raised its dividend for 31 consecutive years with a forward yield of 3%, and its software and consulting services account for 78% of total revenue, providing stable cash flow and dividend support amid economic fluctuations.
See More
Comparative Income Outlook for Philip Morris and Altria
- Income Growth Comparison: While Altria's forward yield stands at 5.9%, Philip Morris's 3.6% yield may be more attractive over the next decade, as its 15% revenue growth in smoke-free product lines demonstrates stronger market adaptability.
- Market Challenge Analysis: Altria faces significant impacts from the smoking cessation movement in the U.S., leading to a slight revenue decline in 2025 primarily due to a 10% drop in cigarette sales volume, which could affect its future dividend growth capacity.
- Patent Risk for Pharmaceuticals: Merck's Keytruda is set to lose some patent protections by 2028; although management anticipates that its new drug portfolio could generate over $70 billion in annual revenue in the next decade, the challenge of replacing Keytruda remains daunting.
- Uniqueness of IBM: International Business Machines (IBM) stands out as a technology stock offering a 3% dividend yield, with its core business model focused on software and consulting services, ensuring stable recurring revenue that is ideal for holding during economic volatility.
See More
Investment Opportunities in Consumer Staples Sector
- Philip Morris Growth Potential: Despite declining cigarette volumes, Philip Morris International (PM) demonstrates strong pricing power that drives sales growth, with an expected organic revenue increase of 5% to 7% in 2023, while its smoke-free products like Iqos and Zyn saw market sales growth of 11% and 10%, respectively, indicating future growth potential.
- Coca-Cola Brand Strength: Coca-Cola (KO) leverages its strong brand equity and global marketing strategies, achieving 10% organic revenue growth in Q1, with concentrate sales rising by 8%, and projecting 4% to 5% organic revenue growth and 8% to 9% EPS growth for the year, reflecting robust performance amid market recovery.
- Chewy's Margin Expansion: Online pet retailer Chewy (CHWY) achieved an 8.3% revenue growth through its autoship model, with EBITDA margins increasing to 5.7%, and is projected to expand margins by another 100 basis points this year, with a long-term goal of reaching 10%, showcasing the attractiveness of its business model and profitability growth.
- Defensive Nature of Consumer Staples: The consumer staples sector is viewed as a defensive investment during economic downturns, and while tech stocks attract attention, companies like Philip Morris, Coca-Cola, and Chewy exhibit strong investment value through stable growth and solid financial performance.
See More
Solid Growth in Consumer Staples Sector
- Philip Morris Growth Potential: Despite declining cigarette volumes, Philip Morris International (NYSE: PM) demonstrates strong pricing power that drives sales growth, with an expected organic revenue increase of 5% to 7% this year, while its smoke-free products like Iqos and Zyn are also contributing to growth, achieving 11% and 10% sales growth respectively, showcasing the company's competitive advantage in its transformation.
- Coca-Cola's Brand Strength: Coca-Cola (NYSE: KO) achieved 10% organic revenue growth in Q1, with concentrate sales rising 8%, benefiting from the introduction of zero-calorie and prebiotic products, and is projecting 4% to 5% organic revenue growth for the year, highlighting its strong brand influence and market recovery potential.
- Chewy's Margin Expansion: Online pet retailer Chewy (NYSE: CHWY) grew its revenue by 8.3% last year, with EBITDA margins increasing by 90 basis points to 5.7%, and is expected to expand margins by another 100 basis points this year, indicating strong growth and profitability potential in the e-commerce sector.
- Investment Opportunities in Consumer Staples: While consumer staples stocks may not attract as much attention as tech stocks, their stable growth and recession-resistant characteristics make them ideal for investors, especially in the context of increasing economic uncertainty, prompting a focus on these robust business models.
See More
Philip Morris Submits SEC Filing for Two-Part Notes Offering; Size Remains Undisclosed
Legal Filing: Philip Morris has filed for two-part notes offering, indicating a strategic financial move.
Size Confidentiality: The specific size of the offering has not been disclosed, maintaining confidentiality in the details.
See More
PMI Recognized for Fourth Year in Forbes Net Zero Leaders List
- Net Zero Progress: PMI has been recognized for the fourth consecutive year in Forbes' Net Zero Leaders list, showcasing its significant achievements in advancing climate action across global operations, marking its commitment to achieving net zero emissions by 2040, ahead of most companies targeting 2050.
- Industry Leadership: PMI ranked first in the fast-moving consumer goods category and fourth overall, reflecting its excellent risk management, operational strength, and governance capabilities, further solidifying its leadership position in climate action.
- Climate Strategy Enhancement: PMI published an updated Climate Transition Plan outlining actions, governance, timelines, and targets to achieve net zero GHG emissions by 2040, demonstrating the company's firm commitment to long-term value creation.
- Investment and Innovation: Since 2008, PMI has invested over $16 billion in developing smoke-free products, with an estimated 43% of net revenues coming from these products by 2025, indicating the strategic importance of driving sustainable development and market transformation.
See More
Analysts Predict Market Returns for the Next Decade
- Market Return Expectations: Vanguard anticipates average annual returns of only 4% to 5% over the next decade, while Goldman Sachs' Peter Oppenheimer believes U.S. stocks will underperform compared to global markets, highlighting increasing market uncertainty.
- Tobacco Industry Comparison: While Altria Group boasts a forward dividend yield of 5.9%, Philip Morris International's 3.6% yield is backed by stronger performance, particularly with a 15% revenue growth in smoke-free products, indicating a long-term competitive edge.
- Pharmaceutical Industry Challenges: Merck's cancer drug Keytruda will lose patent protections starting in 2028; however, the company expects to generate over $70 billion in annual revenue in the next decade, showcasing the potential of its new product pipeline.
- Uniqueness of Tech Stocks: IBM, a technology company, has raised its dividend for 31 consecutive years with a forward yield of 3%, and its software and consulting services account for 78% of total revenue, providing stable cash flow and dividend support amid economic fluctuations.
See More
Comparative Income Outlook for Philip Morris and Altria
- Income Growth Comparison: While Altria's forward yield stands at 5.9%, Philip Morris's 3.6% yield may be more attractive over the next decade, as its 15% revenue growth in smoke-free product lines demonstrates stronger market adaptability.
- Market Challenge Analysis: Altria faces significant impacts from the smoking cessation movement in the U.S., leading to a slight revenue decline in 2025 primarily due to a 10% drop in cigarette sales volume, which could affect its future dividend growth capacity.
- Patent Risk for Pharmaceuticals: Merck's Keytruda is set to lose some patent protections by 2028; although management anticipates that its new drug portfolio could generate over $70 billion in annual revenue in the next decade, the challenge of replacing Keytruda remains daunting.
- Uniqueness of IBM: International Business Machines (IBM) stands out as a technology stock offering a 3% dividend yield, with its core business model focused on software and consulting services, ensuring stable recurring revenue that is ideal for holding during economic volatility.
See More
Investment Opportunities in Consumer Staples Sector
- Philip Morris Growth Potential: Despite declining cigarette volumes, Philip Morris International (PM) demonstrates strong pricing power that drives sales growth, with an expected organic revenue increase of 5% to 7% in 2023, while its smoke-free products like Iqos and Zyn saw market sales growth of 11% and 10%, respectively, indicating future growth potential.
- Coca-Cola Brand Strength: Coca-Cola (KO) leverages its strong brand equity and global marketing strategies, achieving 10% organic revenue growth in Q1, with concentrate sales rising by 8%, and projecting 4% to 5% organic revenue growth and 8% to 9% EPS growth for the year, reflecting robust performance amid market recovery.
- Chewy's Margin Expansion: Online pet retailer Chewy (CHWY) achieved an 8.3% revenue growth through its autoship model, with EBITDA margins increasing to 5.7%, and is projected to expand margins by another 100 basis points this year, with a long-term goal of reaching 10%, showcasing the attractiveness of its business model and profitability growth.
- Defensive Nature of Consumer Staples: The consumer staples sector is viewed as a defensive investment during economic downturns, and while tech stocks attract attention, companies like Philip Morris, Coca-Cola, and Chewy exhibit strong investment value through stable growth and solid financial performance.
See More
Solid Growth in Consumer Staples Sector
- Philip Morris Growth Potential: Despite declining cigarette volumes, Philip Morris International (NYSE: PM) demonstrates strong pricing power that drives sales growth, with an expected organic revenue increase of 5% to 7% this year, while its smoke-free products like Iqos and Zyn are also contributing to growth, achieving 11% and 10% sales growth respectively, showcasing the company's competitive advantage in its transformation.
- Coca-Cola's Brand Strength: Coca-Cola (NYSE: KO) achieved 10% organic revenue growth in Q1, with concentrate sales rising 8%, benefiting from the introduction of zero-calorie and prebiotic products, and is projecting 4% to 5% organic revenue growth for the year, highlighting its strong brand influence and market recovery potential.
- Chewy's Margin Expansion: Online pet retailer Chewy (NYSE: CHWY) grew its revenue by 8.3% last year, with EBITDA margins increasing by 90 basis points to 5.7%, and is expected to expand margins by another 100 basis points this year, indicating strong growth and profitability potential in the e-commerce sector.
- Investment Opportunities in Consumer Staples: While consumer staples stocks may not attract as much attention as tech stocks, their stable growth and recession-resistant characteristics make them ideal for investors, especially in the context of increasing economic uncertainty, prompting a focus on these robust business models.
See More
Philip Morris Submits SEC Filing for Two-Part Notes Offering; Size Remains Undisclosed
Legal Filing: Philip Morris has filed for two-part notes offering, indicating a strategic financial move.
Size Confidentiality: The specific size of the offering has not been disclosed, maintaining confidentiality in the details.
See More
